CBD Epilepsy Policy 
The Cannigma
JULY 18, 2025
The cannabis movement began with a mission rooted in compassion—dedicated to providing relief for patients suffering from severe conditions such as HIV/AIDS, cancer, epilepsy, and chronic pain. He was also looking for a high-CBD strain suitable for inhalation. For her, these tax policies have been devastating. It’s my medicine.”
Veriheal
JUNE 19, 2025
A 2025 BBC report revealed that at least 382 families, identified through online forums and interviews conducted by the parent support charity MedCan, are sourcing cannabis medicines illegally—many to manage severe forms of epilepsy that conventional treatments have failed to control.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Project CBD
NOVEMBER 7, 2018
How often have we heard, “More research is needed,” from those who would prefer to see no change in policies that should be informed by science? How about not enough to eliminate all uncertainties, but enough to recommend medical treatment or change policy? It begs the question: When is there “enough” research?
Project CBD
NOVEMBER 7, 2018
How often have we heard, “More research is needed,” from those who would prefer to see no change in policies that should be informed by science? How about not enough to eliminate all uncertainties, but enough to recommend medical treatment or change policy? It begs the question: When is there “enough” research?
Project CBD
FEBRUARY 28, 2023
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. E-commerce sales of CBD in the U.S. Consumers spent roughly $31.3
NORML
AUGUST 26, 2019
The passage of SB 701 directed the Virginia Board of Pharmacy to regulate and monitor the state’s CBD- and THC-A-rich oils. For comparison, other Southern states such as Texas and Georgia only allow CBD oils (with pretty much zero THC-A) for marijuana patients. As in, no to anyone who wasn’t an epilepsy patient.].
MJ Business Attorneys
JULY 29, 2019
market for CBD continues to skyrocket and companies competing in the cannabis space become more developed, they are being held back by the slow federal regulatory response at the Food and Drug Administration. ” Curaleaf is the first multistate CBD company to receive such a notice from the FDA. CBD sales by 2023.
Expert insights. Personalized for you.
52 
Let's personalize your content